Newly constructed apartments stand in the suburb of Putney Hill in Sydney, Australia, on Sunday, Jan. 8, 2017. Australian house values increased at the fastest pace in seven years in 2016, as record-low interest rates helped fuel demand for property despite warnings such price increases may be unsustainable. Photographer: Brendon Thorne/Bloomberg
Bloomberg
Allianz SE has agreed to become a stakeholder in AI-powered insurtech company Lemonade, with a promise to quickly expand the carrier’s worldwide market reach.
The investment follows three funding rounds totaling $60 million for the high-profiled startup since December 2015. No details of the deal were disclosed.
"We follow the insurtech space closely and globally, and have seen nothing to match Lemonade in terms of technology, user experience and business model innovation,” said Solmaz Altin, Allianz’s chief digital officer, in a statement.
Like many carriers, Allianz is on the hunt for the next big thing in insurance technology. Its insurtech unit, Allianz X, is tasked with finding startups that can transform the digital experience of its customers. The German insurer now joins General Catalyst, Tusk Ventures, XL Innovate, among others, as minority stakeholders in Lemonade, which launched in New York last year but plans to be in almost all U.S. states by the end of 2017. It was approved to operate in Illinois earlier this month.
"Allianz is rightly regarded as one of the most forward thinking companies in our industry," said Daniel Schreiber, cofounder and CEO of Lemonade. "Despite their unparalleled reach and resources, Allianz has no competitive business with Lemonade, and we look forward to deepening our relationship with them in the years to come."
Nick Gerhart, executive VP at the insurer specializing in funeral and end-of-life coverage, spoke about its technology advances, and the role of insurtech on a broader scale in the industry.
Elizabeth Tyndell, VP talent acquisition at New York Life, shares how the insurer is leveraging AI to attract and retain the next generation of insurance talent.
Leveraging EHRs, medical claims and historical lab data, insurers can enhance their ability to discover undisclosed tobacco use and improve risk assessment accuracy.
A group led by Bain Capital's special-situations arm is in talks to invest as much as $2 billion in insurance broker Acrisure, according to people with knowledge of the matter.
